Wednesday, December 4, 2013

CMS Will Switch To Centralized Coverage Review Of IDE Trials, But Not Until 2015

CMS Will Switch To Centralized Coverage Review Of IDE Trials, But Not Until 2015-thegraysheet: CMS will go forward with its recent proposal to centralize the review of investigational device exemption study coverage, but will delay implementation of the new approach until Jan. 1, 2015. The agency explained the new process in its 2014 physician fee schedule final rule (PDF), released Nov. 27. The rule also creates a new set of criteria that IDE studies must be met to gain Medicare coverage.